Skinabin 1% (Cream)

15 gm tube: ৳ 80.00

Medicine Details

Category Details
Generic Terbinafine hydrochloride
Company Aci limited
Also available as

Indications

  • Treatment of onychomycosis of the toenail or fingernail
  • Treatment of Tinea Capitis
  • Treatment of fungal infections of the skin
  • Treatment of tinea infections of the skin
  • Treatment of Pityriasis versicolor

Pharmacology

Inhibition of biosynthesis of Ergosterol via inhibition of Squalene Epoxidase enzyme

Dosage & Administration

  • Terbinafine tablet:
    • For toenail onychomycosis: 250 mg (one tablet) once daily for 12 weeks
    • For fingernail onychomycosis: 250 mg (one tablet) once daily for 6 weeks
  • Terbinafine granules:
    • 125 mg/day for body weight <25 kg
    • 187.5 mg/day for body weight 25-35 kg
    • 250 mg/day for body weight >35 kg for up to 6 weeks
  • Terbinafine cream: Applied once or twice daily for various durations depending on the type of infection
  • Terbinafine 1% Spray: Applied once or twice daily for various durations depending on the type of infection

Interaction

Inhibitor of the CYP450 2D6 isozyme, requiring careful monitoring and potential dose reduction of drugs metabolized by this isozyme

Contraindications

Contra-indicated in individuals hypersensitive to terbinafine

Side Effects

  • Gastrointestinal symptoms
  • Liver test abnormalities
  • Rashes
  • Urticaria
  • Pruritus
  • Taste disturbances
  • Idiosyncratic and symptomatic hepatic injury
  • Skin reactions
  • Neutropenia
  • Thrombocytopenia
  • Angioedema
  • Malaise
  • Fatigue
  • Vomiting
  • Arthralgia
  • Myalgia
  • Hair loss

Pregnancy & Lactation

  • Terbinafine tablet: Not recommended during pregnancy or nursing
  • Terbinafine cream: Not recommended during pregnancy or nursing

Precautions & Warnings

  • Warnings:
    • Rare cases of liver failure
    • Serious skin reaction
    • External use only for cream
  • Precautions: Not recommended for patients with chronic or active liver disease

Use in Special Populations

  • Pediatric use: Safety and efficacy not established in pediatric patients
  • Use in the elderly: No evidence to suggest different dosages or side-effects in elderly patients

Overdose Effects

Clinical experience limited, symptoms include nausea, vomiting, abdominal pain, dizziness, rash, frequent urination, and headache

Therapeutic Class

  • Other Antifungal preparations
  • Topical Antifungal preparations

Storage Conditions

Store in a cool and dry place, below 30°C, protect from light

Related Brands